Express Scripts Anticipates Growth In 2005 From Zithromax, Zofran Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
PBM cites anticipated contribution to growth from several first-time generics that could enter the market in 2005. Nevertheless, Express Scripts concedes that generic utilization growth will be weaker in 2005 than in other years. Subsidiary CuraScript will aid PBM's growth by converting clients that use an outside specialty pharmacy provider.